{
    "title": "Drug championed by Trump for coronavirus shows no benefit, possible harm in study awaiting validation",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8243039/Drug-championed-Trump-coronavirus-shows-no-benefit-possible-harm-study-awaiting-validation.html",
    "date": "2020-04-21",
    "keywords": [
        "drug",
        "coronavirus",
        "death",
        "beasley",
        "benefit",
        "risk",
        "analysis",
        "hydroxychloroquine",
        "covid19",
        "va",
        "care",
        "rate",
        "evidence",
        "malaria",
        "president",
        "trump",
        "game",
        "changer",
        "fight",
        "review",
        "attempt",
        "course",
        "respiratory",
        "illness",
        "health",
        "administration",
        "azithromycin",
        "research",
        "publication",
        "journal",
        "result",
        "trial",
        "infection",
        "april",
        "paper",
        "online",
        "threat",
        "community",
        "practice",
        "study",
        "comment",
        "account",
        "hydroxycholoquine",
        "impact",
        "support",
        "ventilation",
        "versus",
        "breathing",
        "assistance",
        "lupus",
        "arthritis",
        "heart",
        "vision",
        "question",
        "role",
        "pandemic",
        "reporting",
        "deena",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}